Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer
The functional expression of the sodium–iodide symporter (NIS) at the membrane of differentiated thyroid cancer (DTC) cells is the cornerstone for the use of radioiodine (RAI) therapy in these malignancies. However, NIS gene expression is frequently downregulated in malignant thyroid tissue, and 30%...
Guardado en:
Autores principales: | Márcia Faria, Rita Domingues, Maria João Bugalho, Ana Luísa Silva, Paulo Matos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfee77cfa51147559414bff5636061dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells
por: Márcia Faria, et al.
Publicado: (2021) -
FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma
por: Mariana Cooke, et al.
Publicado: (2021) -
Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update
por: Maciej Ratajczak, et al.
Publicado: (2021) -
Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes
por: Rebekka Spellerberg, et al.
Publicado: (2021) -
THE NIŠ COOPERATIVE: 1921‒1947
por: DEJAN D. ANTIĆ, et al.
Publicado: (2021)